Collet F, Féve B, Frisdal E, Pavoine C, Pecker F, Atlan G
Institut National de la Santé et de la Recherche Médicale, Unité 296, Faculté de Médecine Hôpital Henri Mondor, Créteil, France.
Respir Physiol. 1998 Apr;112(1):1-12. doi: 10.1016/s0034-5687(98)00019-x.
Using pharmacological and molecular approaches to investigate beta-adrenoceptor (beta-AR) subtype expression in adult rat diaphragm, we found that adenylyl cyclase (AC) was potently stimulated by the beta2-AR-selective agonist fenoterol, weakly stimulated by the beta1-AR-selective agonist prenalterol and unaffected by the beta3-AR agonist CGP12177. AC activity in response to a submaximal isoproterenol concentration was potently inhibited by the beta2-AR-selective antagonist ICI118551, whereas the beta1-AR-selective antagonist CGP20712A was effective only in very high concentrations. (-)-[125I]-cyanopindolol ([125I]-CYP) saturation binding experiments indicated a single affinity component (dissociation constant (Kd) = 22 +/- 2 pM) for beta-AR sites (maximal beta -AR density (Bmax) = 14 +/- 2 fmol/ mg). Eadie-Hofstee analysis of [125I]-CYP displacement curves by beta1-, beta2- or beta3-AR-selective ligands allowed to characterise a homogeneous population of beta2-AR sites. Finally, reverse transcriptase-polymerase chain reaction analysis of beta-AR subtype mRNAs identified beta2-AR transcripts but no beta1- and beta3-AR mRNAs. Our results demonstrate that beta2-AR is the only beta-AR subtype expressed in the diaphragm.
运用药理学和分子生物学方法研究成年大鼠膈肌中β-肾上腺素能受体(β-AR)亚型的表达,我们发现,β2-AR选择性激动剂非诺特罗能有效刺激腺苷酸环化酶(AC),β1-AR选择性激动剂普瑞特罗对其刺激作用较弱,而β3-AR激动剂CGP12177对其无影响。在次最大异丙肾上腺素浓度下,β2-AR选择性拮抗剂ICI118551能有效抑制AC活性,而β1-AR选择性拮抗剂CGP20712A只有在非常高的浓度下才有效。(-)-[125I]-氰基吲哚洛尔([125I]-CYP)饱和结合实验表明,β-AR位点存在单一亲和力成分(解离常数(Kd)=22±2 pM)(最大β-AR密度(Bmax)=14±2 fmol/mg)。通过β1-、β2-或β3-AR选择性配体对[125I]-CYP置换曲线进行伊迪-霍夫斯泰分析,可对β2-AR位点的同质群体进行表征。最后,对β-AR亚型mRNA进行逆转录聚合酶链反应分析,鉴定出β2-AR转录本,但未发现β1-和β3-AR mRNA。我们的结果表明,β2-AR是膈肌中唯一表达的β-AR亚型。